awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33166002-AE90F07E-AE18-4191-8CD0-B21CE08AB3FD
Q33166002-AE90F07E-AE18-4191-8CD0-B21CE08AB3FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33166002-AE90F07E-AE18-4191-8CD0-B21CE08AB3FD
Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis.
P2860
Q33166002-AE90F07E-AE18-4191-8CD0-B21CE08AB3FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33166002-AE90F07E-AE18-4191-8CD0-B21CE08AB3FD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ab60ea9f38718bdcefc249e3e67645b6793245bf
P2860
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.